Press Release AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech MACAO, May 31, 2026 /PRNewswire/ — The BEYOND Expo 2026 has shown what… CISION PRNewswireMay 31, 2026
Press Release Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders SHANGHAI, May 31, 2026 /PRNewswire/ — The 28th Shanghai International Film Festival… CISION PRNewswireMay 31, 2026
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026 Oral presentation of DZD6008 demonstrated strong and durable anti-tumor activity, excellent BBB-penetrant… CISION PRNewswireMay 31, 2026
Press Release Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet CHENGDU, China, May 31, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the… CISION PRNewswireMay 31, 2026
Cyient Enters Agreement to Acquire TAO Digital Acquisition enhances Cyient’s offering portfolio with AI-native data and lifecycle engineering capabilities… CISION PRNewswireMay 31, 2026
Press Release THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI® Millions of fans from across the world tuned in to watch the… CISION PRNewswireMay 31, 2026
Press Release The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet CHENGDU, China, May 30, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.… CISION PRNewswireMay 30, 2026
Press Release Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO CHENGDU, China, May 30, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.… CISION PRNewswireMay 30, 2026
